VENTOLIN EVOHALER 100 mcg

Pajjiż: Singapor

Lingwa: Ingliż

Sors: HSA (Health Sciences Authority)

Ingredjent attiv:

SALBUTAMOL

Disponibbli minn:

GLAXOSMITHKLINE PTE LTD

Kodiċi ATC:

R03AC02

Dożaġġ:

100 mcg

Għamla farmaċewtika:

AEROSOL, SPRAY

Kompożizzjoni:

SALBUTAMOL 100 mcg

Rotta amministrattiva:

RESPIRATORY (INHALATION)

Tip ta 'preskrizzjoni:

Prescription Only

Manifatturat minn:

GLAXO WELLCOME PRODUCTION

L-istatus ta 'awtorizzazzjoni:

ACTIVE

Data ta 'l-awtorizzazzjoni:

2000-07-28

Fuljett ta 'informazzjoni

1 
                              VENTOLIN™
EVOHALER™                   
CFC FREE

SALBUTAMOL 
QUALITATIVE AND QUANTITATIVE COMPOSITION 
_VENTOLIN_ _EVOHALER_ is
a pressurised metered-dose inhaler which delivers 100 mcg 
salbutamol (as sulphate) per actuation, into the mouthpiece of a
specially designed 
actuator.  The inhaler also contains the CFC-free
propellant HFA 134a.  Each canister 
contains at least 200 actuations. 
PHARMACEUTICAL FORM 
Pressurised inhalation, solution. 
CLINICAL PARTICULARS 
INDICATIONS 
_VENTOLIN_ Evohaler provides short-acting (4 to 6
hour) bronchodilation with fast onset 
(within 5 minutes) in reversible airways obstruction.   
It is particularly suitable for the relief and prevention
of asthma symptoms. 
_VENTOLIN_ Evohaler should be used to relieve symptoms when
they occur, and to 
prevent them in those circumstances recognised by the patient to
precipitate an asthmatic 
attack (e.g. before exercise or unavoidable allergen exposure). 
_VENTOLIN _Evohaler is particularly valuable
as relief medication in mild, moderate or 
severe asthma, provided that reliance on
it does not delay the introduction and use of 
regular inhaled corticosteroid therapy. 
Salbutamol is a selective beta
2
 adrenoceptor agonist indicated for the treatment and 
prevention of bronchospasm.
It provides short acting (four hours) bronchodilation in 
reversible airways obstruction. For patients with
asthma salbutamol may be used to 
relieve symptoms when they occur and to prevent them prior to
a known trigger. 
Bronchodilators should not be the only or main treatment in
patients with persistent 
asthma. In patients with
persistent asthma unresponsive to _VENTOLIN_, treatment with 
inhaled corticosteroids is recommended to achieve and maintain
control. Failing to 
respond to treatment with _VENTOLIN_ may signal a need
fo

Karatteristiċi tal-prodott

1 VENTOLIN EVOHALER
CFC FREE
SALBUTAMOL
QUALITATIVE AND QUANTITATIVE COMPOSITION
_VENTOLIN_
Evohaler is a pressurised metered-dose inhaler which delivers 100 mcg
salbutamol (as sulphate) per actuation, into the mouthpiece of a
specially designed
actuator. The inhaler also contains the CFC-free propellant HFA 134a.
Each canister
contains at least 200 actuations.
CLINICAL INFORMATION
INDICATIONS
Pharmaceutical form: Pressurised inhalation, suspension.
_VENTOLIN_
Evohaler provides short-acting (4 to 6 hours) bronchodilation with
fast onset
(within 5 minutes) in reversible airways obstruction.
It is particularly suitable for the relief and prevention of asthma
symptoms.
_VENTOLIN_
Evohaler should be used to relieve symptoms when they occur, and to
prevent them in those circumstances recognised by the patient to
precipitate an asthmatic
attack (e.g. before exercise or unavoidable allergen exposure).
_VENTOLIN _
Evohaler is particularly valuable as relief medication in mild,
moderate or
severe asthma, provided that reliance on it does not delay the
introduction and use of
regular inhaled corticosteroid therapy.
Salbutamol is a selective beta-2 adrenoceptor agonist indicated for
the treatment and
prevention of bronchospasm. It provides short acting (4 hours)
bronchodilation in
reversible airways obstruction. For patients with asthma salbutamol
may be used to
relieve symptoms when they occur and to prevent them prior to a known
trigger.
Bronchodilators should not be the only or main treatment in patients
with persistent
asthma. In patients with persistent asthma unresponsive to
_VENTOLIN_
, treatment with
inhaled corticosteroids is recommended to achieve and maintain
control. Failing to
respond to treatment with
_VENTOLIN_
may signal a need for urgent medical advice or
treatment.
DOSAGE AND ADMINISTRATION
_VENTOLIN _
Evohaler
_ _
is administered by the oral inhaled route only.
_VENTOLIN _
has a duration of action of 4 to 6 hours in most patients.
2
Increasing use of beta-2 agonists may be a sign of worsening asthma.
Unde